| Mrs Susan Elizabeth Brinkoetter, CCC-SLP | |
|
St John's Hospital, 800 E. Carpenter, Springfield, IL 62769-0001 | |
| (217) 544-6464 | |
| Not Available |
| Full Name | Mrs Susan Elizabeth Brinkoetter |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | St John's Hospital, Springfield, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023292125 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 146004488 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Susan Elizabeth Brinkoetter, CCC-SLP St John's Hospital, 800 E. Carpenter, Springfield, IL 62769-0001 Ph: (217) 544-6464 | Mrs Susan Elizabeth Brinkoetter, CCC-SLP St John's Hospital, 800 E. Carpenter, Springfield, IL 62769-0001 Ph: (217) 544-6464 |
News Archive
Endo Pharmaceuticals today announced actions designed to advance the company's leadership and growth in pain management, including an agreement to acquire all outstanding shares of Penwest Pharmaceuticals for $5.00 in cash per share, or an estimated enterprise value of approximately $144 million at the time of deal close. Penwest has been working with Endo since 1997 on the development and commercialization of OPANA® ER and receives a royalty stream on net sales of the product.
A search using medical data bases reveals that hundreds of meta-analysis papers conducted with tens of millions of people worldwide have confirmed clinically the efficacies of thirty antioxidant-rich foods to prevent or treat chronic diseases, including hypertension, diabetes, cardiovascular disease, cognitive impairment, chronic kidney disease, cancer, and more.
Otsuka Pharmaceutical Co., Ltd. (OPC) and Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) announced today that an independent data monitoring committee (IDMC) has recommended the early termination of its Phase 3, 52-week, placebo-controlled, intramuscular depot aripiprazole trial.
The U.S. Food and Drug Administration today warned patients and healthcare providers about the potential for increased risk of muscle injury from the cholesterol-lowering medication Zocor (simvastatin) 80 mg.
Researchers who analyzed data from the 2006-2007 wildfires in Australia found that exposure to wildfire smoke was linked to increased visits to hospital emergency departments for asthma.
› Verified 7 days ago
Madeline Katalinich, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 107 Tamarisk Dr, Springfield, IL 62704 Phone: 217-899-1007 | |
Talking Tots, Professional Corporation Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 41 Claymont Ct, Springfield, IL 62704 Phone: 217-793-3309 | |
Mrs. Lindsay Craddock, M.S.CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 900 N Rutledge St, Springfield, IL 62702 Phone: 217-535-6509 | |
Breanna Paige Kurk, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2807 Catherine Ln, Springfield, IL 62703 Phone: 217-779-7623 | |
Jasmine Schnietz, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1309 S 9th St, Springfield, IL 62703 Phone: 314-282-7526 | |
Paula Dunn, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 45 Glen Eagle Dr, Springfield, IL 62704 Phone: 217-836-0536 |